Literature DB >> 16986031

Complementary and alternative therapies as treatment approaches for interstitial cystitis.

Kristene E Whitmore.   

Abstract

The management of interstitial cystitis (IC) is predominantly the reduction of the symptoms of frequency, urgency, and pain. Multimodal treatment approaches for IC are helpful in customizing therapy for individual patients. Complementary and alternative therapies are a quintessential addition to the therapeutic armamentarium and frequently include dietary modification, nutraceuticals, bladder training, neuromodulation, stress reduction, and sex therapy. Dietary modification involves elimination of bladder irritants, fluid regulation, and a bowel regimen. Nutraceuticals studied for the treatment of IC include calcium glycerophosphate, L-arginine, mucopolysaccharides, bioflavinoids, and Chinese herbs. Bladder training is effective after pain reduction. The neuromodulation of high-tone pelvic-floor muscle dysfunction is achieved with physical therapy and acupuncture. Stress reduction and sex therapy are best administered by a qualified stress manager and sex therapist. Multimodal, nonconventional management may add efficacy to the treatment of IC.

Entities:  

Year:  2002        PMID: 16986031      PMCID: PMC1476005     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  22 in total

1.  The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis.

Authors:  R A Bologna; A Gomelsky; J C Lukban; L M Tu; A S Holzberg; K E Whitmore
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

2.  Treatment of interstitial cystitis with a quercetin supplement.

Authors:  F Katske; D A Shoskes; M Sender; R Poliakin; K Gagliano; J Rajfer
Journal:  Tech Urol       Date:  2001-03

3.  Sacral nerve stimulation for the management of voiding dysfunction.

Authors:  A K Das; M D White; P A Longhurst
Journal:  Rev Urol       Date:  2000

4.  Pain and depression experienced by women with interstitial cystitis.

Authors:  C Rabin; A O'Leary; C Neighbors; K Whitmore
Journal:  Women Health       Date:  2000

5.  Interstitial cystitis: successful management by increasing urinary voiding intervals.

Authors:  C L Parsons; P F Koprowski
Journal:  Urology       Date:  1991-03       Impact factor: 2.649

6.  Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

Authors:  E Rovner; K J Propert; C Brensinger; A J Wein; M Foy; A Kirkemo; J R Landis; J W Kusek; L M Nyberg
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.

Authors:  J J Cartledge; A M Davies; I Eardley
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

8.  Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel; M Lundie
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

9.  A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.

Authors:  G E Korting; S D Smith; M A Wheeler; R M Weiss; H E Foster
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

10.  Behavioral therapy for the treatment of refractory interstitial cystitis.

Authors:  D C Chaiken; J G Blaivas; S T Blaivas
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450

View more
  16 in total

1.  Fluid manipulation among individuals with lower urinary tract symptoms: a mixed methods study.

Authors:  Emily A Elstad; Nancy N Maserejian; John B McKinlay; Sharon L Tennstedt
Journal:  J Clin Nurs       Date:  2010-11-15       Impact factor: 3.036

2.  Treatment effectiveness in interstitial cystitis/bladder pain syndrome: Do patient perceptions align with efficacy-based guidelines?

Authors:  Avril Lusty; Elizabeth Kavaler; Kay Zakariasen; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

3.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

4.  Interstitial cystitis patients' use and rating of complementary and alternative medicine therapies.

Authors:  Peter Gregory O'Hare; Amy Rejba Hoffmann; Penny Allen; Barbara Gordon; Linda Salin; Kristene Whitmore
Journal:  Int Urogynecol J       Date:  2012-11-14       Impact factor: 2.894

5.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

Review 6.  Overactive bladder and pain: management strategies.

Authors:  Bhavin N Patel; Robert J Evans
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 7.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 8.  What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Authors:  Abhishek Seth; Joel M H Teichman
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

9.  Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial.

Authors:  Gregory Kanter; Yuko M Komesu; Fares Qaedan; Peter C Jeppson; Gena C Dunivan; Sara B Cichowski; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2016-04-26       Impact factor: 2.894

Review 10.  [Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Authors:  T Bschleipfer; R Doggweiler; D Schultz-Lampel; J de Jong; A Gonsior; J Hensen; E Heßdörfer; B T Kaftan; A Kuhn; U Kunzendorf; A Lampel; A Landmesser; A Loch; O Moormann; B Müller; J Neuhaus; A Reich; R Roth; S Schumacher; R Stratmeyer; W Vahlensieck; A Wördehoff; B Münder-Hensen
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.